Boston Scientific(US:BSX) ZACKSยท2025-06-13 23:01Group 1: Stock Performance - Boston Scientific (BSX) closed at $99.74, marking a +1.2% move from the prior day, outperforming the S&P 500's daily loss of 1.13% [1] - Over the last month, BSX shares have decreased by 6.01%, underperforming the Medical sector's gain of 3.07% and the S&P 500's gain of 3.55% [1] Group 2: Upcoming Earnings - Boston Scientific is projected to report earnings of $0.72 per share, representing year-over-year growth of 16.13% [2] - The Zacks Consensus Estimate for revenue is projecting net sales of $4.89 billion, up 18.63% from the year-ago period [2] Group 3: Annual Forecast - For the entire year, the Zacks Consensus Estimates forecast earnings of $2.91 per share and revenue of $19.49 billion, indicating changes of +15.94% and +16.4%, respectively, compared to the previous year [3] Group 4: Analyst Estimates - Recent changes to analyst estimates for Boston Scientific reflect shifting dynamics of short-term business patterns, with positive revisions indicating analysts' confidence in business performance and profit potential [4] Group 5: Zacks Rank and Valuation - The Zacks Rank system, which includes estimate changes, currently ranks Boston Scientific at 3 (Hold) [6] - Boston Scientific is trading with a Forward P/E ratio of 33.83, compared to the industry average of 19.2, indicating a premium valuation [7] Group 6: PEG Ratio and Industry Ranking - Boston Scientific has a PEG ratio of 2.55, while the industry average PEG ratio is 2.28 [8] - The Medical - Products industry has a Zacks Industry Rank of 146, placing it within the bottom 41% of over 250 industries [8]